HeartSciences SG&A Expenses 2022-2024 | HSCS
HeartSciences sg&a expenses from 2022 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| HeartSciences Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $2 |
| 2021 | $1 |
| HeartSciences Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-01-31 | $1 |
| 2023-10-31 | $1 |
| 2023-07-31 | $1 |
| 2023-04-30 | $1 |
| 2023-01-31 | $1 |
| 2022-10-31 | $1 |
| 2022-07-31 | $1 |
| 2022-04-30 | $1 |
| 2022-01-31 | $0 |
| 2021-10-31 | $0 |
| 2021-07-31 | $0 |
| 2021-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.992B | 19.76 |
| Hims & Hers Health (HIMS) | United States | $4.758B | 0.00 |
| Tempus AI (TEM) | United States | $4.172B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.020B | 0.00 |
| Axonics (AXNX) | United States | $3.455B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.168B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.167B | 0.00 |
| Azenta (AZTA) | United States | $2.962B | 166.54 |
| Enovis (ENOV) | United States | $2.469B | 18.30 |
| 10x Genomics (TXG) | United States | $2.369B | 0.00 |
| Privia Health (PRVA) | United States | $2.012B | 112.40 |
| Schrodinger (SDGR) | United States | $1.411B | 0.00 |
| Omnicell (OMCL) | United States | $1.252B | 43.29 |
| Phreesia (PHR) | United States | $1.163B | 0.00 |
| Standard BioTools (LAB) | United States | $0.667B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.632B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.630B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.301B | 0.00 |
| Pulmonx (LUNG) | United States | $0.238B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.197B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.180B | 0.00 |
| TruBridge (TBRG) | United States | $0.160B | 8.60 |
| American Well (AMWL) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.078B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.067B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
| Augmedix (AUGX) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.030B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Movano (MOVE) | United States | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |